NASDAQ: NKGNNkgen Biotech Inc Stock Ownership - Who owns Nkgen Biotech?
Insider buying vs selling
Have Nkgen Biotech Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul Y. Song | Chief Executive Officer | 2023-12-07 | 76 | $3.29 | $250.04Buy |
| Paul Y. Song | Chief Executive Officer | 2023-12-06 | 75 | $3.32 | $249.00Buy |
| Paul Y. Song | Chief Executive Officer | 2023-12-05 | 105 | $3.33 | $349.65Buy |
| Paul Y. Song | Chief Executive Officer | 2023-12-04 | 162 | $3.07 | $497.34Buy |
| James A. Graf | Interim CFO | 2023-12-04 | 450 | $3.19 | $1.44kBuy |
| James A. Graf | Interim CFO | 2023-12-01 | 220 | $3.35 | $737.00Buy |
| Paul Y. Song | Chief Executive Officer | 2023-11-27 | 140 | $2.85 | $399.00Buy |
| Paul Y. Song | Chief Executive Officer | 2023-11-27 | 103 | $2.91 | $299.73Buy |
| Paul Y. Song | Chief Executive Officer | 2023-11-22 | 52 | $2.85 | $148.20Buy |
| Paul Y. Song | Chief Executive Officer | 2023-11-21 | 100 | $2.80 | $280.00Buy |
NKGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NKGN insiders and whales buy or sell their stock.
NKGN Shareholders
What type of owners hold Nkgen Biotech Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sangwoo Park | 46.12% | 10,517,990 | $20.83M | Insider |
| James A. Graf | 29.33% | 6,689,937 | $13.25M | Insider |
| Graf Acquisition Partners Iv LLC | 10.68% | 2,436,744 | $4.82M | Insider |
| Meteora Capital LLC | 7.00% | 1,596,817 | $3.16M | Institution |
| Polar Asset Management Partners Inc | 4.74% | 1,080,000 | $2.14M | Institution |
| University Of Chicago | 2.41% | 550,000 | $1.09M | Institution |
| Sandia Investment Management LP | 1.94% | 442,622 | $876.39k | Institution |
| Paul Y. Song | 0.75% | 171,120 | $338.82k | Insider |
| Geode Capital Management LLC | 0.20% | 45,850 | $90.78k | Institution |
| Yong Man Kim | 0.12% | 28,384 | $56.20k | Insider |
NKGN vs Biotech Stocks
Nkgen Biotech Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.